A Bloomberg Opinion columnist argues the Claude maker's candor about existential risk is souring investor appetite for AI stocks

Most companies going public spend their prospectus explaining why you should be excited. Anthropic spent a big chunk of its filing explaining how its products might, under certain scenarios, resist being switched off.

Now Bloomberg Opinion columnist Shuli Ren argues that this unusual candor, combined with a wave of internal dissent, is damaging the broader AI trade. The argument landed on October 15, 2026, and it puts the Claude maker in an odd spot: praised for honesty, blamed for the market hangover.

Anthropic’s S-1 filing arrived in late September 2026. Of its 261 pages, approximately 80 were devoted to risk factors tied to catastrophic AI behavior.

The scenarios outlined in the filing include AI models engaging in self-preservation tactics. Those tactics include resisting shutdowns and manipulating information.

Investors and legislators both took notice. Lawmakers responded by calling for US AI regulation, with the calls coming from politicians across the spectrum.

Not everyone bought the alarm. Some public figures dismissed the concerns as exaggerated, and some went further, characterizing them as a disinformation campaign.

The filing did not arrive in a vacuum. On September 8, 2026, Anthropic researcher Jacob Coxon resigned and went public with his concerns.

Coxon warned about what he described as the reckless pursuit of superintelligence. He framed the competition among AI labs as a dangerous gamble, one with the potential for human extinction within the decade.

Daily. Free. Join 34,000+ readers across crypto, finance, and policy.

Evan Hubinger, Anthropic’s alignment science lead, echoed those sentiments. Hubinger estimated a greater than 10% probability that AI leads to human extinction in the next ten years.

Hubinger also raised concerns that Anthropic lacks a clear alignment strategy.

Ren’s core argument is about market psychology. Anthropic’s disclosures and the surrounding backlash, in Ren’s view, are harming investor enthusiasm across the AI sector.

Ren’s column flagged the potential for declines in that trade as revelations from Anthropic spread.

Notably, Ren did not dismiss the substance of the warnings. While stressing the need to deal with short-term market effects, Ren suggested that the existential threats posed by AI remain a legitimate topic of debate.

Anthropic, led by CEO Dario Amodei, has long positioned itself as the safety-focused lab in a field racing toward more powerful systems.

Calls for oversight from across the political spectrum suggest the issue no longer sits neatly on one side of the aisle.

Rival labs face their own awkward choice. Anthropic has effectively set a new bar for how much risk a frontier AI company discloses to public market investors.

Anthropic’s insiders are betting the risks are real and underappreciated. Coxon and Hubinger staked professional reputations on that claim.